173 related articles for article (PubMed ID: 31712387)
1. Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans.
Song S; Thomas IC; Ganesan C; Sohlberg EM; Chertow GM; Liao JC; Conti S; Elliott CS; Pao AC; Leppert JT
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1773-1780. PubMed ID: 31712387
[TBL] [Abstract][Full Text] [Related]
2. Real-World Effectiveness of Preventive Pharmacological Therapy in Patients With Urolithiasis: A Retrospective Cohort Study.
Hollingsworth JM; Oerline MK; Hsi RS; Crivelli JJ; Krampe N; Asplin JR; Shahinian VB
Am J Kidney Dis; 2024 Jul; 84(1):83-93.e1. PubMed ID: 38432593
[TBL] [Abstract][Full Text] [Related]
3. Preventive Pharmacological Therapy and Risk of Recurrent Urinary Stone Disease.
Arivoli K; Valicevic AN; Oerline MK; Hsi RS; Patel SR; Hollingsworth JM; Shahinian VB
Clin J Am Soc Nephrol; 2024 May; 19(5):565-572. PubMed ID: 38345854
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of twenty-four hour urine testing in Veterans with urinary stone disease.
Ganesan C; Thomas IC; Song S; Sun AJ; Sohlberg EM; Kurella Tamura M; Chertow GM; Liao JC; Conti S; Elliott CS; Leppert JT; Pao AC
PLoS One; 2019; 14(8):e0220768. PubMed ID: 31393935
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones.
Goldfarb DS; MacDonald PA; Gunawardhana L; Chefo S; McLean L
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1960-7. PubMed ID: 23929928
[TBL] [Abstract][Full Text] [Related]
6. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic treatment of uric acid calculi.
Preminger GM
Urol Clin North Am; 1987 May; 14(2):335-8. PubMed ID: 3576854
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone and electrolytes during long-term treatment with allopurinol and thiazide.
Kohri K; Takada M; Katoh Y; Kataoka K; Iguchi M; Yachiku S; Kurita T
Br J Urol; 1987 Jun; 59(6):503-7. PubMed ID: 3690177
[TBL] [Abstract][Full Text] [Related]
9. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].
Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O
Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144
[TBL] [Abstract][Full Text] [Related]
10. Twenty-four-hour Urine Testing and Urinary Stone Disease Recurrence in Veterans.
Song S; Thomas IC; Ganesan C; Velaer KN; Chertow GM; Pao AC; Leppert JT
Urology; 2022 Jan; 159():33-40. PubMed ID: 34688771
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease.
Hsi RS; Yan PL; Crivelli JJ; Goldfarb DS; Shahinian V; Hollingsworth JM
Urology; 2022 Aug; 166():111-117. PubMed ID: 35545149
[TBL] [Abstract][Full Text] [Related]
12. Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis.
Höbarth K; Hofbauer J; Szabo N
Urology; 1994 Jul; 44(1):20-4; discussion 24-5. PubMed ID: 8042263
[TBL] [Abstract][Full Text] [Related]
13. Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.
Fuselier HA; Moore K; Lindberg J; Husserl FE; Cole FE; Kok DJ; Whitehead D; Galliano DJ; Erwin DT
Urology; 1998 Dec; 52(6):988-94. PubMed ID: 9836542
[TBL] [Abstract][Full Text] [Related]
14. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
15. Kidney stones: current issues in diagnosis and therapy.
Brown DC
Postgrad Med; 1982 Dec; 72(6):124-33. PubMed ID: 6755415
[TBL] [Abstract][Full Text] [Related]
16. Kidney stones. Medical management and newer options for stone 'removal'.
Kanig SP; Conn RL
Postgrad Med; 1985 Nov; 78(6):38-44, 47-51. PubMed ID: 4059131
[TBL] [Abstract][Full Text] [Related]
17. How are urine composition and stone disease affected by therapeutic measures at an outpatient stone clinic?
Tiselius HG; Sandvall K
Eur Urol; 1990; 17(3):206-12. PubMed ID: 2351189
[TBL] [Abstract][Full Text] [Related]
18. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers.
Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R
Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031
[TBL] [Abstract][Full Text] [Related]
19. Radiographic and laboratory data ("the Megaprofile") can accurately guide medical management in the absence of stone analysis.
Best SL; Sivalingam S; Penniston KL; Nakada SY
J Endourol; 2015 Mar; 29(3):357-61. PubMed ID: 25025627
[TBL] [Abstract][Full Text] [Related]
20. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
